emgality
Treatment for Cluster Headache
Emgality (galcanezumab) is a calcitonin gene-related peptide (CGRP) monoclonal antibody that works by specifically binding and neutralizing CGRP, a neuropeptide involved in pain transmission and vasodilation. By inhibiting CGRP, Emgality reduces neurogenic inflammation and pain signaling, thereby decreasing the frequency and severity of cluster headache episodes.
2090
REPORTED SIDE EFFECTS